Literature DB >> 333124

Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse.

S Green, A Dobrjansky, M A Chiasson, E Carswell, M K Schwartz, L J Old.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 333124     DOI： 10.1093/jnci/59.5.1519

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  38 in total

1.  Role of tumour necrosis factor in the tumour-necrotizing activity of agents with diverging toxicity.

Authors:  P A van de Wiel; A van der Pijl; N Bloksma
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 2.  Use of immune modulators in nonspecific therapy of bacterial infections.

Authors:  M T Vogels; J W van der Meer
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

3.  A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity.

Authors:  A A Creasey; R Yamamoto; C R Vitt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  Macrophage functions in Biozzi mice.

Authors:  H M Dockrell; J Taverne; R Lelchuk; P Depledge; I N Brown; J H Playfair
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

5.  Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant.

Authors:  S Kotani; H Takada; M Tsujimoto; T Ogawa; I Takahashi; T Ikeda; K Otsuka; H Shimauchi; N Kasai; J Mashimo
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

6.  Synergic action between tumor necrosis factor and endotoxins or poly(A.U) on cultured bovine endothelial cells.

Authors:  P A van de Wiel; R H Pieters; A van der Pijl; N Bloksma
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor.

Authors:  K Haranaka; E A Carswell; B D Williamson; J S Prendergast; N Satomi; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

8.  Possible importance of macrophage-derived mediators in acute malaria.

Authors:  I A Clark; J L Virelizier; E A Carswell; P R Wood
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

9.  Production of lymphocyte activating factor in vivo.

Authors:  P R Wood; L Andrus; I A Clark
Journal:  Immunology       Date:  1983-12       Impact factor: 7.397

10.  Induction of macrophage-mediated production of tumor necrosis factor alpha by an L-form derived from Staphylococcus aureus.

Authors:  K Kuwano; A Akashi; I Matsu-ura; M Nishimoto; S Arai
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.